Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer the fragmin advanced malignancy outcome study (FAMOUS) - Kakkar, AK; Levine, MN; Kadziola, Z; Lemoine, NR; Low, V; Patel, HK; Rustin, G; Thomas, M; Quigley, M; Williamson, RC (J Clin Oncol, 2004)